04-8443. Memorandum of Understanding Between the Department of Health and Human Services of the United States Through the Food and Drug Administration and the Ministry of Maritime Affairs and Fisheries of the Republic of Korea Covering the Safety ...  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Department of Health and Human Services of the United States of America through the Food and Drug Administration (FDA) and the Ministry of Maritime Affairs and Fisheries of the Republic of Korea. This understanding is in keeping with the beneficial and cooperative work conducted under the terms of a 1988 MOU concerning the safety and quality of molluscan shellfish exported to the United States from the Republic of Korea. The purpose of the MOU is to establish the set of guidelines to be implemented for assuring that molluscan shellfish exported from the Republic of Korea and offered for import into the United States of America are safe for human consumption and are harvested, processed, transported, and labeled in accordance with the provision of the U.S. National Shellfish Sanitation Program and the applicable requirements of the U.S. Federal Food and Drug and Cosmetic Act, the U.S. Public Health Service Act, the U.S. Fair Packaging and Labeling Act, and title 21 of the U.S. Code of Federal Regulations.

    DATES:

    The agreement became effective October 28, 2003.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Paul W. Distefano, Center for Food Safety and Applied Nutrition (HFS-417), Food and Drug Administration, College Park, MD 20740, 301-436-1410.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

    Start Signature

    Dated: March 24, 2004.

    Jeffrey Shuren,

    Assistant Commissioneer for Policy.

    End Signature Start Printed Page 20014

    Start Printed Page 20015

    Start Printed Page 20016

    Start Printed Page 20017

    Start Printed Page 20018

    Start Printed Page 20019

    Start Printed Page 20020

    Start Printed Page 20021

    Start Printed Page 20022

    End Supplemental Information

    BILLING CODE 4160-01-S

    Start Printed Page 20023[FR Doc. 04-8443 Filed 4-14-04; 8:45 am]

    BILLING CODE 4160-01-C

Document Information

Effective Date:
10/28/2003
Published:
04/15/2004
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
04-8443
Dates:
The agreement became effective October 28, 2003.
Pages:
20013-20023 (11 pages)
Docket Numbers:
FDA 225-04-8006
PDF File:
04-8443.pdf